Literature DB >> 17714449

A proposed structural basis for picrotoxinin and picrotin binding in the glycine receptor pore.

Zhe Yang1, Brett A Cromer, Robert J Harvey, Michael W Parker, Joseph W Lynch.   

Abstract

Picrotoxin, an antagonist of structurally-rated GABA(A) receptors (GABA(A)Rs) and glycine receptors (GlyRs), is an equimolar mixture of picrotoxinin (PTXININ) and picrotin (PTN). These compounds share a common structure except that PTN contains a slightly larger dimethylmethanol in place of the PTXININ isopropenyl group. Although the homomeric alpha1 GlyR is equally sensitive to both compounds, we show here that homomeric alpha2 and alpha3 GlyRs, like most GABA(A)Rs, are selectively inhibited by PTXININ. As conservative mutations to pore-lining 6' threonines equally affect the sensitivity of the alpha1 GlyR to both compounds, we conclude that PTXININ and PTN bind to 6' threonines by hydrogen bonding with exocyclic oxygens common to both molecules. In contrast, substitution of the 2' pore-lining glycine by serine selectively reduces PTN sensitivity, whereas the introduction of 2' alanines selectively increases PTXININ sensitivity. These results define the orientation of PTXININ and PTN binding in the alpha1 GlyR pore and allow us to conclude that the relatively reduced sensitivity of PTN at GABA(A)Rs and alpha2 and alpha3 GlyRs is due predominantly to its larger size and reduced ability to form hydrophobic interactions with 2' alanines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714449     DOI: 10.1111/j.1471-4159.2007.04850.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Cys-loop receptor channel blockers also block GLIC.

Authors:  Mona Alqazzaz; Andrew J Thompson; Kerry L Price; Hans-Georg Breitinger; Sarah C R Lummis
Journal:  Biophys J       Date:  2011-12-20       Impact factor: 4.033

2.  Ligand- and subunit-specific conformational changes in the ligand-binding domain and the TM2-TM3 linker of {alpha}1 {beta}2 {gamma}2 GABAA receptors.

Authors:  Qian Wang; Stephan A Pless; Joseph W Lynch
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

3.  Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.

Authors:  Wei Xiong; Shao-Rui Chen; Liming He; Kejun Cheng; Yi-Lin Zhao; Hong Chen; De-Pei Li; Gregg E Homanics; John Peever; Kenner C Rice; Ling-gang Wu; Hui-Lin Pan; Li Zhang
Journal:  Nat Neurosci       Date:  2014-01-05       Impact factor: 24.884

4.  Ethanol Modulation is Quantitatively Determined by the Transmembrane Domain of Human α1 Glycine Receptors.

Authors:  Suzzane Horani; Evan P Stater; Pierre-Jean Corringer; James R Trudell; R Adron Harris; Rebecca J Howard
Journal:  Alcohol Clin Exp Res       Date:  2015-05-14       Impact factor: 3.455

Review 5.  Inhibitory glycine receptors: an update.

Authors:  Sébastien Dutertre; Cord-Michael Becker; Heinrich Betz
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

6.  Mechanism of action of the insecticides, lindane and fipronil, on glycine receptor chloride channels.

Authors:  Robiul Islam; Joseph W Lynch
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 7.  Molecular targets and mechanisms for ethanol action in glycine receptors.

Authors:  Daya I Perkins; James R Trudell; Daniel K Crawford; Ronald L Alkana; Daryl L Davies
Journal:  Pharmacol Ther       Date:  2010-04-23       Impact factor: 12.310

8.  Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor.

Authors:  A J Thompson; R K Duke; S C R Lummis
Journal:  Mol Pharmacol       Date:  2011-04-19       Impact factor: 4.436

9.  Defective glycinergic synaptic transmission in zebrafish motility mutants.

Authors:  Hiromi Hirata; Eloisa Carta; Iori Yamanaka; Robert J Harvey; John Y Kuwada
Journal:  Front Mol Neurosci       Date:  2010-01-08       Impact factor: 5.639

10.  Presynaptic calcium signalling in cerebellar mossy fibres.

Authors:  Louiza B Thomsen; Henrik Jörntell; Jens Midtgaard
Journal:  Front Neural Circuits       Date:  2010-02-08       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.